SAMSUNG BIOLOGICS

samsung-biologics-logo

Samsung Biologics was founded in April 2011 with a vision to become the most competitive Contract Development and Management Organization (CDMO) in the biopharmaceutical industry. The company was established by Samsung Electronics Co., Samsung Everland Inc., Samsung C&T Corp., and Quintiles Transnational Corp. Their headquarters are located in Incheon, South Korea, with plans to expand globally. Samsung holds fast to the Quality First principles on which it was founded. To that end, they strive... to offer outstanding quality, innovation, and availability to their clients. This allows Samsung Biologics' partners to provide the most effective medicines to their end patients with cost savings and in the most efficient manner possible. To achieve their Quality First vision, Samsung has created a continual processing platform. This platform facilitates the manufacturing of biopharmaceutical products with the highest innovations in execution and quality. The advanced engineering used to build this process allows for both efficient production and absolute compliance with the vast number of global regulatory bodies involved in the creation of biopharmaceutical products. Samsung Biologics has a track record and reputation for excellence. These accolades extend to plant design, construction, operations, and execution. They strive to provide the highest quality and efficiency available in the CDMO biopharmaceutical space and have succeeded in offering their partners the means to create and distribute medicines, meeting the standards in the industry. The Samsung Biologics Quality Division oversees all operations and works strenuously to evaluate compliance with international regulatory and cGMP requirements. Their facilities are known for innovative engineering that brings products from inception and early-stage development all the way through the process until they meet the high standards necessary to enter the commercial supply chain. Samsung Biologics plans to continue the expansion of facilities and capabilities to meet the needs of the growing market. Dr. Tae Han Kim serves as the Chief Executive Officer of Samsung Biologics. Dr. Kim began his career with Samsung in 1979 and has been an integral member of senior leadership on several expansion projects, as well as leading the business and financial restructuring of Samsung General Chemicals. Dr. Kim holds a doctoral degree in chemical engineering.

#SimilarOrganizations #People #Financial #Event #Website #More

SAMSUNG BIOLOGICS

Social Links:

Industry:
Biotechnology Health Care Manufacturing

Founded:
2011-04-22

Address:
Incheon, Inch'on-jikhalsi, South Korea

Country:
South Korea

Website Url:
http://www.samsungbiologics.com

Total Employee:
1001+

Status:
Active

Contact:
+82-32-455-3114

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving Apache


Similar Organizations

biotech-logo

Biotech

Biotech is a healthcare company.

not_available_image

EssCo

EssCo is a stealth health Care company.

hh-biotechnology-holdings-co-logo

HH Biotechnology Holdings Co

HH Biotechnology Holdings Co is a healthcare company.

nell-hodgson-woodruff-school-of-nursing-logo

Nell Hodgson Woodruff School of Nursing

Nell Hodgson Woodruff School of Nursing is a health care company.

not_available_image

SA Biotech

SA Biotech is a Healthcare company.

shengmei-biotech-logo

Shengmei Biotech

Shengmei Biotech is a Healthcare company.

usv-private-limited-logo

USV Private Limited

USV Private Limited is a leading healthcare company.

Current Employees Featured

not_available_image

John Rim
John Rim Chief Executive Officer & President @ Samsung BioLogics
Chief Executive Officer & President
2020-12-01

dr-tae-han-kim_image

Dr. Tae Han Kim
Dr. Tae Han Kim President & Chair of BOD @ Samsung BioLogics
President & Chair of BOD

Founder


dr-tae-han-kim_image

Dr. Tae Han Kim

Acquisitions List

Date Company Article Price
2022-04-20 Samsung Bioepis Samsung Bioepis acquired by Samsung BioLogics N/A

Official Site Inspections

http://www.samsungbiologics.com Semrush global rank: 2.23 M Semrush visits lastest month: 8.64 K

  • Host name: 49.238.237.51
  • IP address: 49.238.237.51
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Samsung BioLogics"

Samsung Biologics - Wikipedia

Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea.The biotech division of Samsung Group, its …See details»

Fact Sheet | About Us - About Us | Samsung Biologics

Mar 31, 2023 - What are cookies? A cookie is a small text file that a website saves on your computer or mobile device when you visit the Website. It enables the Website to remember your actions and preferences (such as language …See details»

Samsung Biologics - LinkedIn

Samsung Biologics is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest ...See details»

Samsung Biologics - Craft

Oct 29, 2024 Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization. It provides cell line development, final aseptic fill, laboratory …See details»

Samsung Biologics (KRX:207940) Company Profile & Description

Mar 13, 2025 Samsung Biologics Co.,Ltd. engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South …See details»

SAMSUNG BIOLOGICS

See you at CPHI Barcelona . Samsung Biologics is a fully integrated CDMO providing true end-to-end services to secure the success of your project's entire lifecycle.See details»

Samsung Biologics Company - PitchBook

Dec 29, 2020 www.samsungbiologics.com. Ownership Status. Publicly Held. Financing Status. Corporation. Corporate Office. ... Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing …See details»

SAMSUNG BIOLOGICS - Overview, News & Similar companies

Recorded Q1'24 consolidated revenue of KRW 946.9 billion Recorded Q1'24 consolidated operating profit of KRW 221.3 billion Sustained growth driven by ongoing strategic expansion …See details»

The Leading Global CDMO with End-to-End Services

Mar 31, 2023 At Samsung Biologics, our innovation starts with the best People, specifically “Pi Type” people who are not only rooted in more than one field of expertise, but also with the ability to span their influence across the …See details»

Samsung BioLogics - Crunchbase Investor Profile

Samsung Biologics was founded in April 2011 with a vision to become the most competitive Contract Development and Management Organization (CDMO) in the biopharmaceutical industry. The company was established by Samsung …See details»

Samsung Biologics’ Manufacturing Capabilities for Complex …

Oct 14, 2024 By Lalit Saxena, Senior Director of MSAT, and Sungkeum Seo, Director of MSAT Labs Upstream Processing at Samsung BiologicsIntroduction | The biopharmaceutical industry …See details»

Samsung Biologics presents business updates at 2025 J.P. Morgan ...

Jan 15, 2025 Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its latest business achievements and …See details»

Samsung Biologics - LinkedIn

Samsung Biologics | 52,043 followers on LinkedIn. Innovation, passion and an unwavering dedication to find breakthrough solutions in biomedicines. | Samsung Biologics is a fully …See details»

Samsung Biologics’ Super Plant 4, How the world’s largest ...

This month, Samsung Biologics commenced GMP operations at its newest Plant 4. With the world’s largest contract manufacturing capacity, the company plans to maximize operational …See details»

Samsung Biologics extends collaboration with LigaChem …

Jan 9, 2025 Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced to extend collaboration with LigaChem …See details»

Samsung Biologics on track to meet global demand with high …

1 day ago Samsung Biologics on track to meet global demand with high-tech facilities CEO John Rim outlines strategy for ramping up biopharma manufacturing withSee details»

The Leading Global CDMO with End-to-End Services - Samsung …

- What are cookies? A cookie is a small text file that a website saves on your computer or mobile device when you visit the Website. It enables the Website to remember your actions and …See details»

Inside the futuristic biotech startup Cellares that’s building a cure ...

4 days ago Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in fundingSee details»

The Leading Global CDMO with End-to-End Services - Samsung …

As a global leading contract development and manufacturing organization (CDMO) we appreciate the need for trusted partnerships and the flexibility required for our clients to deliver their.. …See details»

What defines a quality culture at Samsung Biologics?

Dec 12, 2024 Quality teams can also be a proactive partner within the company, informing other teams of how processes are run in faraway corners of the organization. “Each team may not …See details»

linkstock.net © 2022. All rights reserved